Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
822.51
+0.84 (0.10%)
At close: Mar 28, 2025, 4:00 PM
815.45
-7.06 (-0.86%)
After-hours: Mar 28, 2025, 7:57 PM EDT
Eli Lilly Employees
Eli Lilly and Company had 47,000 employees as of December 31, 2024. The number of employees increased by 4,000 or 9.30% compared to the previous year.
Employees
47,000
Change (1Y)
4,000
Growth (1Y)
9.30%
Revenue / Employee
$958,355
Profits / Employee
$225,319
Market Cap
738.61B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 47,000 | 4,000 | 9.30% |
Dec 31, 2023 | 43,000 | 4,000 | 10.26% |
Dec 31, 2022 | 39,000 | 4,000 | 11.43% |
Dec 31, 2021 | 35,000 | 0 | - |
Dec 31, 2020 | 35,000 | 1,375 | 4.09% |
Dec 31, 2019 | 33,625 | -5,055 | -13.07% |
Dec 31, 2018 | 38,680 | -1,975 | -4.86% |
Dec 31, 2017 | 40,655 | -1,320 | -3.14% |
Dec 31, 2016 | 41,975 | 700 | 1.70% |
Dec 31, 2015 | 41,275 | 2,140 | 5.47% |
Dec 31, 2014 | 39,135 | 1,210 | 3.19% |
Dec 31, 2013 | 37,925 | -425 | -1.11% |
Dec 31, 2012 | 38,350 | 270 | 0.71% |
Dec 31, 2011 | 38,080 | -270 | -0.70% |
Dec 31, 2010 | 38,350 | -2,010 | -4.98% |
Dec 31, 2009 | 40,360 | -140 | -0.35% |
Dec 31, 2008 | 40,500 | -100 | -0.25% |
Dec 31, 2007 | 40,600 | -900 | -2.17% |
Dec 31, 2006 | 41,500 | -1,100 | -2.58% |
Dec 31, 2005 | 42,600 | -1,900 | -4.27% |
Dec 31, 2004 | 44,500 | -1,600 | -3.47% |
Dec 31, 2003 | 46,100 | 2,400 | 5.49% |
Dec 31, 2002 | 43,700 | 2,600 | 6.33% |
Dec 31, 2001 | 41,100 | 5,400 | 15.13% |
Dec 31, 2000 | 35,700 | 4,400 | 14.06% |
Dec 31, 1999 | 31,300 | 1,500 | 5.03% |
Dec 31, 1998 | 29,800 | -1,300 | -4.18% |
Dec 31, 1997 | 31,100 | 1,900 | 6.51% |
Dec 31, 1996 | 29,200 | 2,400 | 8.96% |
Dec 31, 1995 | 26,800 | 1,900 | 7.63% |
Dec 31, 1994 | 24,900 | -7,800 | -23.85% |
Dec 31, 1993 | 32,700 | 500 | 1.55% |
Dec 31, 1992 | 32,200 | 1,400 | 4.55% |
Dec 31, 1991 | 30,800 | 1,300 | 4.41% |
Dec 31, 1990 | 29,500 | 1,700 | 6.12% |
Dec 31, 1989 | 27,800 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
LLY News
- 1 hour ago - Eli Lilly Vs. Novo Nordisk: Which Is The Better Bargain For Investors - Seeking Alpha
- 1 day ago - Eli Lilly Stock Up 1% After Key Signal, Despite S&P 500's ~2% Drop - Benzinga
- 1 day ago - CHMP Recommends Against Approval of Eli Lilly's Kisunla Alzheimer's Drug -- Update - Market Watch
- 1 day ago - EU medicines regulator rejects Eli Lilly's Alzheimer's drug - Reuters
- 2 days ago - VIG: Index Rebalance Adds Eli Lilly To Bolster Dividend Growth In 2025 - Seeking Alpha
- 2 days ago - Trump Weighs Tariffs on Ireland's Pharma Industry. How to Play the Sector. - Market Watch
- 2 days ago - Lilly adds Alzheimer's to online offerings - Reuters
- 3 days ago - Eli Lilly, Palo Alto Networks Traders Take Note: Direxion's New Leveraged ETFs Are Here - Benzinga